Livingstone Health Holdings Limited · SGX:PRH
Livingstone Health — Investor Presentation (February 2021)
24 slides from Livingstone Health's investor presentation, February 2021
Slide 1: Livingstone Health – Unveiling Asian-Focused Holistic Healthcare Group
Livingstone Health – Unveiling Asian-Focused Holistic Healthcare Group CORPORATE PRESENTATION
Slide 2: Table of Contents
1. Reverse Takeover: A New Turning Point 2. Who We Are 3. Our Locations 4. Board of Directors 5. Management 6. Key Milestones Tableofof Table 7. Industry Overview – Why Livingstone? Contents Contents 8. Competitive Strengths 9. Financial Highlights 10.Outlook and Strategies 11.Key Investment Merits
Slide 3: Disclaimer
Disclaimer This presentation is prepared for information purposes only, without regard to the objectives, financial situation nor needs of any specific person. Neither this presentation nor any of its content may be distributed, reproduced, or used without the prior written consent of Livingstone He
Slide 4: Reverse Takeover: A New Turning Point
Reverse Takeover: A New Turning Point On 22 January 2021, shareholders of Citicode Ltd. approved the reverse takeover (“RTO”) of Livingstone Health Limited for a consideration of up to S$72 million. Citicode’s shares will be transferred from the SGX Mainboard to the Catalist Board, and change its co
Slide 5: Who We Are
The name “Livingstone” is inspired from the succulent plant Lithops, also known as “living stones”. They symbolise the Company’s resilience, growth and determination to be recognised as a trust integrated healthcare provider and a centre of excellence for medical professionals. Who We Are
Slide 6: Our Locations
Our Locations The Group has 15 doctors in 12 medical clinics and one medical spa located around Singapore, as well as a joint venture in Cambodia
Slide 7: Board of Directors
Board of Directors Teh Wing Kwan Dr Wilson Tay Fong Heng Boo Non-Independent and Executive Director and Lead Independent Director Non-Executive Chairman Chief Executive Officer Steven Lim Chan Yu Meng Independent Director Independent Director
Slide 8: Management
Management Dr Sebastian Chua Dr Wilson Tay Dax Ng Dr Rachel Lim Chief Medical Officer Executive Director and Chief Business Officer Chief Operating Officer Chief Executive Officer Dr Edwin Tan Leow Chin Yew Cindy Lau Head of Orthopaedic Surgery Group Financial Controller Head of Operations
Slide 9: Key Milestones
Key Milestones 2015 2016 2017 2018 2019 2020 2021 Ardmore Medical The Group’s first The Company was In October 2018, the The Group’s first foray overseas In November 2020, On 4 February 2021, Group was specialist clinic, incorporated on 1 Group acquired via a joint venture agreement to Livingstone L
Slide 10: Industry Overview – Why Livingstone?
Industry Overview – Why Livingstone?
Slide 11: Ageing Population in Singapore & Globally
▪ Estimated that around 32% of Singaporeans will be aged 65 and above by 2035^ ▪ Median age is also expected to rise from Ageing 39.7 in 2015 to 53.4 in 2050^ Population in ▪ In Eastern and South-eastern Asia, the population of people aged 65 and older is Singapore projected to grow to 573 million i
Slide 12: Rising Affluence in Singapore & Asia Pacific
Rising Affluence in Singapore & Asia Pacific
Slide 13: Rising Affluence in Singapore & Asia Pacific: Household Income and Health Spending
Singapore median monthly household income from Total Private Consumption Expenditure on Health work per household member (S$) (S$' Billion) * 3,500 14.0 12.8 2,925 12.0 3,000 10.0 8.6 2,500 1,848 8.0 2,000 6.0 1,500 4.0 1,000 2.0 500 0.0 2012 2018 0 2010 2019 Total Private Consumption Expenditure on
Slide 14: Healthier & More Active Lifestyle in Singapore
Healthier & More Active Lifestyle ▪ Greater focus on healthy and active living by the government and people of Singapore will in Singapore increase demand for high-quality specialist healthcare to prevent, detect and treat ailments, diseases, health hazards, etc. ▪ The Health Promotion Board has int
Slide 15: Growing Uptake of Private Healthcare Insurance
Growing Uptake of Private Healthcare • Continued growth in the life insurance industry despite Singapore’s muted economic growth in Insurance 2019^ • Total sum assured for life insurers’ new business achieved year-on-year growth of 7% to reach S$149.5 billion in 2019^ • Life Insurance industry recor
Slide 16: Medical Tourism In Singapore
One of the leading destinations in Asia Pacific region for medical tourism Medical Tourism In Placed 2nd in the world by the Medical Tourism Index 2020 – 2021 Singapore High quality healthcare and health services because of its developed healthcare infrastructure, top medical expertise, political st
Slide 17: Competitive Strengths
Competitive Strengths Multidisciplinary approach to specialist healthcare – The Group’s integrated network allows for a more patient-centric and multidisciplinary approach to healthcare management and treatment. Organic growth model underpinned by a dynamic and experienced management team – 15 Medic
Slide 18: Financial Highlights: Revenue
Financial Highlights Revenue (S$'000) 16,000 14,000 12,000 10,000 8,000 14,345 6,000 4,000 6,159 6,487 2,000 4,411 2,547 1,501 0 Audited FY2017 Audited FY2018 Audited FY2019 Pro Forma FY2019 Unaudited 6M2019 Unaudited 6M2020
Slide 19: Financial Highlights: Net Profit
Financial Highlights Net Profit Attributable to Owners of the Target Company (S$'000) 3,500 3,000 2,500 1,384 2,000 1,500 1,410 1,000 1,913 1,820 1,683 817 500 904 420 405 0 69 Audited FY2017 Audited FY2018 Audited FY2019 Pro Forma FY2019 Unaudited 6M2019 Unaudited 6M2020 Attributable to Continuing
Slide 20: Financial Highlights: Adjusted NPAT
Financial Highlights Adjusted NPAT (S$'000)(1) 3,500 3,000 2,500 2,000 3,223 1,500 1,000 1,942 1,283 500 993 0 69 Audited FY2017 Audited FY2018 Pro Forma FY2019 Unaudited 6M2019 Unaudited 6M2020 (1) For illustrative purposes only. Adjusted NPAT is computed as the audited consolidated net profit afte
Slide 21: Outlook and Strategies
= SS Jutlook and Strategies
Slide 22: Outlook and Strategies
❑ Capitalise on the fast-growing healthcare sector by o Expanding our existing range of medical services to complement our multidisciplinary approach o Recruiting highly-qualified and talented management and healthcare professionals ❑ Expand throughout the Asia and beyond o This will be achieved via
Slide 23: Key Investment Merits
Key Investment Merits ▪ Multidisciplinary Specialist Healthcare Approach a. Asset-light business b. Strong track record of profitability ▪ Well positioned to capture growing market share amid trends such as: a. Ageing population b. Rising affluence c. Healthier and more active lifestyles d. Growing
Slide 24: Thank You
THANK YOU This set of slides has been reviewed by the Company's sponsor, SAC Capital Private M E D I A & I N V E STO R C O N TAC T: Limited (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes W E
Livingstone Health Holdings — Investor Presentation (February 2021) on 6ix